Categories: News

NYSE Content Advisory: Pre-Market update + McGraw Hill, Accelerant IPO on NYSE

NEW YORK, July 24, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.

- Advertisement -

Ashley Mastronardi delivers the pre-market update on July 24th

- Advertisement -
  • Stocks are mixed Thursday morning following the S&P 500’s 12th record close of the year on Wednesday. The index received a boost Tuesday night when President Trump announced a trade deal with Japan.
  • The NYSE was in attendance at the All In’s AI Summit and before President Trump gave his closing keynote, spoke to leaders on a cross-section of topics including AI, energy, robotics, infrastructure, and legislation
  • Education solutions firm McGraw Hill, which raised nearly $415 million in its IPO will debut on the NYSE today. Specialty risk company Accelerant, which raised over $723 million, will debut as well.
  • The New York Stock Exchange announced this morning that NYSE Texas has listed its first exchange traded funds, with Strive Asset Management dual-listing 13 ETFs

Opening Bell
McGraw Hill celebrates its IPO on the New York Stock Exchange

- Advertisement -

Closing Bell
The Autism Science Foundation and Wall Street Rides FAR celebrate the 11th season of Rides FAR and its support for innovative autism research.

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2737653/NYSE_Market_Update_July_24.mp4

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–mcgraw-hill-accelerant-ipo-on-nyse-302513148.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

3 weeks ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

3 weeks ago

Secret Ingredient’s 2025: Redefining Hospitality through Story, Space and Strategy

NEW DELHI, Dec. 31, 2025 /PRNewswire/ -- Secret Ingredient, one of India's foremost food and…

1 month ago

GAC Receives Industry’s First Vehicle Data Security Management System Certificate

TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December 24th, GAC received…

1 month ago